MedPath

广东方盛健盟药业有限公司

Ownership
-
Established
2021-07-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

养血祛风止痛颗粒

Approval Number
国药准字Z20250006
Approval Date
Jun 3, 2025
NMPA

Compound Rhizome and Indometacin Capsules

Product Name
复方川芎吲哚美辛胶囊
Approval Number
国药准字H46020617
Approval Date
Aug 10, 2020
NMPA

Compound Pubescent Angelica and Indometacin Capsules

Product Name
复方独活吲哚美辛胶囊
Approval Number
国药准字H46020616
Approval Date
Aug 10, 2020
NMPA

舒尔经胶囊

Approval Number
国药准字Z20025985
Approval Date
Aug 10, 2020
NMPA

西洋参胶囊

Approval Number
国药准字Z20027544
Approval Date
Jul 28, 2020
NMPA

龙血竭散

Approval Number
国药准字Z20026373
Approval Date
Jul 10, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.